US Patent & Trademark Office

Viatris challenges Novo Nordisk’s patent on diabetes drug semaglutide

In Viatris’ ambitious bid to be the first to introduce generic versions of Novo Nordisk’s blockbuster diabetes and obesity drugs, ...